-------- Original Message --------
This week's FierceBiotech is brought to you by BioWorld Today.
|
 | Dear Colleague- Addex Pharmaceuticals SA is laying off around a quarter of its work force in order to conserve cash and focus its resources on priority projects. The company aims to realize around CHF8 million (US$9.5 million) in annual savings as a result of the measure, which will extend its cash runway by six to nine months, out to the end of 2013. (from Bioworld Today - 7/8/11) Read this story and more in BioWorld Today, the world’s leading biotechnology news and information source for 20 years. Delivered to your desktop every single business day, Bioworld Today gives you all the news you need to know to make good business decisions in the day ahead, you’ll learn: - What your competitors are doing … so you can easily identify opportunities and threat s.
- Where the smart money is going … where top investors are placing their bets and who is raising funds.
- The latest technological innovations and discoveries … to clinical study results across the industry.
- What the FDA and Congress are up to… so you can prepare for coming changes, and recent approvals.
Start your Risk-Free subscription today and save over 50%! Best Regards, Jennifer Boggs
Assistant Managing Editor, BioWorld Today | 
For questions or comments call Customer Service at 404-262-5547 | New Edition! 
Learn More | | Get Connected! | |
Want to reach 80,000+ FierceBiotech subscribers with your own message?
Contact ryan@fiercemarkets.com or call 202-824-5089.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech. Click here to unsubscribe.
FierceMarkets 1900 L St. NW Suite 400 Washington, DC 20036 |
